Infectious Disease

UK approves COVID-19 vaccine developed by AstraZeneca, Oxford

December 30, 2020

1 min read

ADD SUBJECT TO EMAIL ALARMS

Receive an email when new articles are published

Please enter your email address to receive an email when new articles are published . “data-action =” subscribe “> subscribe

We could not process your request. Please try again later. If you continue to have this problem, please contact customerservice@slackinc.com.

Back to Healio

The UK was the first country to approve the COVID-19 vaccine jointly developed by AstraZeneca and Oxford University.

The UK’s Medicines and Health Products Regulatory Authority (MHRA) approved the two-dose vaccine for use in adults aged 18 and over, with a second dose given 4 to 12 weeks after the first dose.

Covid vaccination

Oxford and AstraZeneca’s COVID-19 vaccine has been approved by the UK Medicines and Health Products regulator.
Photo credit: Adobe Stock

Study data showed that two standard doses of the vaccine against COVID-19 were 62.1% effective, while in participants who received half a dose followed by a standard dose, with an average effectiveness of 70%, 90% effective. .

Unlike some other COVID-19 vaccines, the AstraZeneca / Oxford vaccine can be stored at temperatures above freezing between 36 ° F and 46 ° F, much like a traditional refrigerator, which means it can be stored and administered in existing healthcare facilities can. British health officials noted.

“This approval means that more people can be protected from this virus and save lives.” June Raine, Managing Director of MHRA said in a press release. “This is another important milestone in the fight against this virus. We will continue to support the health system and work to ensure that COVID-19 vaccines are introduced safely across the UK. Protecting health and improving life is our mission and goal. “

The MHRA said it will continue to test vaccines to ensure their safety and quality.

ADD SUBJECT TO EMAIL ALARMS

Receive an email when new articles are published

Please enter your email address to receive an email when new articles are published . “data-action =” subscribe “> subscribe

We could not process your request. Please try again later. If you continue to have this problem, please contact customerservice@slackinc.com.

Back to Healio

COVID-19 Resource Center

COVID-19 Resource Center

Related Articles